Encompass Health Corporat... (EHC)
NYSE: EHC
· Real-Time Price · USD
119.07
-0.68 (-0.57%)
At close: Jun 20, 2025, 3:59 PM
119.18
0.09%
After-hours: Jun 20, 2025, 05:29 PM EDT
Encompass Health Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Inpatient Revenue | 5.23B |
| Inpatient Revenue Growth | n/a |
| Outpatient and Other Revenue | 142.7M |
| Outpatient and Other Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 52.3M | 69.2M | 54M | 50.5M | 50.2M | 53.1M | 722.6M | 705.9M | 686.2M | 670.3M | 655.9M | 853.4M | 845.3M | 841.6M | 793.8M | 782.6M | 746M | 744.3M | 724.3M | 715.2M | 734.9M | 753.1M | 735.1M | 720.3M | 693.8M | 687.9M | 661.8M | 652.6M | 649.9M | 616.4M | 600.4M | 598.5M | 584.5M | 570.9M | 545.3M | 540.1M | 536.2M | 519.9M | 460.6M | 446.5M | 434M |
| Selling, General, and Administrative Revenue Growth | -24.42% | +28.15% | +6.93% | +0.60% | -5.46% | -92.65% | +2.37% | +2.87% | +2.37% | +2.20% | -23.14% | +0.96% | +0.44% | +6.02% | +1.43% | +4.91% | +0.23% | +2.76% | +1.27% | -2.68% | -2.42% | +2.45% | +2.05% | +3.82% | +0.86% | +3.94% | +1.41% | +0.42% | +5.43% | +2.66% | +0.32% | +2.40% | +2.38% | +4.69% | +0.96% | +0.73% | +3.14% | +12.87% | +3.16% | +2.88% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |